The International Map of Axial Spondyloarthritis (IMAS) has been chosen as the winner of the Connecting Healthcare 2021 Award from more than 60 entries from across Europe from a variety of collaborative projects. The Connecting Healthcare Award is an initiative of the European Federation of Pharmaceutical Industries and Associations (EFPIA) that seeks to highlight innovative…
A total of 468 patients with migraine were analyzed, of whom 38.5% had migraine 15 or more days per month. The risk of anxiety was higher in patients suffering from migraine 3 or more days per month, while those with 19 or more migraine days per month were at risk of depression. In addition, patients…
After the Cypriot League Against Rheumatism (CYPLAR), the patient association leading the Cypriot part of the REUMAVID project, sent the first press release with the main findings of the REUMAVID study to the media, TV channels contacted them to interview them about the study and its objectives. Souzi Makri, President of CYPLAR and partner and…
A new article from the IMAS project, entitled “Gender differences in Patient Journey to Diagnosis and Disease Outcomes: results from the European Map of Axial Spondyloarthritis (EMAS)” has been published in the journal Clinical Rheumatology. Historically, axSpA has been conceived as a predominantly male disease, which could imply a bias during diagnosis and treatment of…
The costs of 475 migraine patients in Spain were analyzed, resulting in a total annual cost of €16,578.2 for patients with chronic migraine and €6,227.8 for patients with episodic migraine. In addition, a higher degree of disability, according to MIDAS, significantly increased the total cost of migraine, while the presence of psychiatric comorbidity increased costs…
Ankylosing spondylitis is a chronic immune-mediated inflammatory disease affecting the joints of the spine, whose main symptom is inflammatory low back pain. Its onset occurs between 20-30 years of age and in Spain up to 500,000 people suffer from it. The REUMAVID study, a survey of 465 Spanish rheumatic patients, has quantified the impact of…
1800 patients with 15 different rheumatic diseases participated in the first phase of REUMAVID. During the onset of the COVID-19 pandemic, more than half of the patients cancelled their appointment with the rheumatologist. In addition, many of them increased the consumption of harmful habits (24.6% smoked more and 18.2% consumed more alcohol) and decreased the…
The importance for wellbeing of having views of nature from and in the home during the COVID-19 pandemic. Results from the GreenCOVID study Marco Garrido-Cumbrera, Ronan Foley, José Correa-Fernández, Alicia González-Marín, Olta Braçe, and Denise Hewlett J Environ Psychol. 2022 Objective The COVID-19 pandemic has influenced the daily lives of people and may affect their…
Similarities and differences between non-radiographic and radiographic axial spondyloarthritis: The patient perspective from the Spanish atlas Marco Garrido-Cumbrera, Jordi Gratacos, Eduardo Collantes-Estevez, Pedro Zarco, Carlos Sastre, Sergio Sanz-Gómez and Victoria Navarro-Compán Reumatología clínica. 2022 Objective Although non-radiographic axial spondyloarthritis (EspAax-nr) is well understood within health institutions, being considered along with radiographic EspAax (EspAax-r) as part…
Exploring the role of rheumatic and musculoskeletal disease patient organisations during the COVID-19 pandemic: results from the REUMAVID study (phase 1) Marco Garrido-Cumbrera, Helena Marzo-Ortega, Laura Christen, José Correa-Fernández, Sergio Sanz-Gómez, Victoria Navarro-Compán, REUMAVID Working Group. Clin Exp Rheumatol. 2022. Objective This study aims to assess the role of RMD POs during the COVID-19 pandemic.…
